BioCentury
ARTICLE | Clinical News

Epizyme, Eisai preclinical data

March 3, 2014 8:00 AM UTC

In a mouse xenograft model of enhancer of zeste homolog 2 (EZH2)-mutant bearing NHL, EPZ-6438 led to dose-dependent tumor growth inhibition, including complete and sustained regressions. Additionally...